These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3190164)

  • 1. [The value of measuring membrane potentials of urothelial cells using cytofluorometry in the study of tumors of the bladder. Preliminary analysis].
    Nicolas J; Vieillefond A; Benoit G; Jardin A; Neveux Y; Martin E
    Ann Urol (Paris); 1988; 22(4):246-8. PubMed ID: 3190164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiparameter analysis using flow cytometry as additional tool for bladder cancer diagnosis].
    Knuechel R; Wieland W; Nicolai H; Hofstaedter F
    Verh Dtsch Ges Pathol; 1993; 77():204-8. PubMed ID: 7511281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric detection and quantitation of the epidermal growth factor receptor in comparison to Scatchard analysis in human bladder carcinoma cell lines.
    Brockhoff G; Hofstaedter F; Knuechel R
    Cytometry; 1994 Sep; 17(1):75-83. PubMed ID: 8001460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image analysis and flow cytometry of tumors of prostate and bladder; with a comment on molecular biology of urothelial tumors.
    Koss LG; Czerniak B
    Monogr Pathol; 1992; (34):112-28. PubMed ID: 1406738
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
    Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
    Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inverted type urothelial cell bladder papillomas. Three new cases (author's transl)].
    Bernheim J; Aronheim M; Griffel B
    J Urol (Paris); 1980; 86(1):57-61. PubMed ID: 7391595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.
    Lascombe I; Clairotte A; Fauconnet S; Bernardini S; Wallerand H; Kantelip B; Bittard H
    Clin Cancer Res; 2006 May; 12(9):2780-7. PubMed ID: 16675571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
    Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens.
    Lapham RL; Grignon D; Ro JY
    Semin Diagn Pathol; 1997 May; 14(2):109-22. PubMed ID: 9179972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression.
    Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE
    Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification of the expressivity of blood group antigens in urothelial bladder tumors. Prognostic value].
    Roth A; Le Cuziat N; Cukier J
    J Urol (Paris); 1983; 89(4):225-31. PubMed ID: 6350478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
    Shen YJ; Ye DW; Yao XD; Trink B; Zhou XY; Zhang SL; Dai B; Zhang HL; Zhu Y; Guo Z; Wu G; Nagpal J
    BJU Int; 2008 Jan; 101(1):113-9. PubMed ID: 17941920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
    Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution pattern of urothelial associated glycoproteins in human bladder cancer cell lines in in vitro culture].
    Knuechel R; Meckl S; Masters JR; Hofstaedter F
    Verh Dtsch Ges Pathol; 1993; 77():256-9. PubMed ID: 7511293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of tumor location of urothelial tumors of the bladder, after total cystectomy].
    Martin M; Bernardini S; Kleinclauss F; Della Negra E; Henry PC; Bittard H
    Prog Urol; 2002 Dec; 12(6):1221-7. PubMed ID: 12545628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA ploidy and cell cycle phase analysis with flow cytometry in bladder wash. Preliminary experience].
    Rivas del Fresno M; Salas Bustamante A; Suárez González JA; Tardón García A; Sampedro Nuño A
    Arch Esp Urol; 2000; 53(1):29-36. PubMed ID: 10730422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of cytofluorometry in bladder tumors].
    Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
    Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.